Economic evaluation of medication therapeutical management services for patients with stable coronary heart disease
- VernacularTitle:稳定性冠心病患者实施药物治疗管理服务的经济学评价
- Author:
Huanhuan JIANG
1
;
Zijian WANG
2
;
Zhixiu WANG
1
;
Xiulin GU
1
;
Shizi LI
1
Author Information
1. Dept. of Pharmacy，the Second Affiliated Hospital of Hebei North University，Hebei Zhangjiakou 075100，China
2. Dept. of Cardiology，the Second Affiliated Hospital of He bei North University，Hebei Zhangjiakou 075100，China
- Publication Type:Journal Article
- Keywords:
medication thera peutical management;
stable coronary disease;
economic evaluation;
pharmaceutical care
- From:
China Pharmacy
2022;33(8):981-986
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To ex plore the economic value of medication therapeutical management （MTM）service for patients with stable coronary disease. METHODS Totally 140 patients with stable coronary disease were divided into a control group and a intervention group ，70 cases in each group. Patients in control group were received routine medical services ，and patients in intervention group additionally received standardized MTM services on this basis. Medication complication ，satisfaction degree ， safety indexes and efficacy indexes were compared between 2 groups. From the perspective of the whole society ，the economic value of MTM service for patients with stable coronary disease were evaluated by pharmacists using cost minimization analysis. RESULTS A total of 15 patients did not complete the study ，including 5 cases in intervention group and 10 cases in control group ； there was no death endpoint during the follow-up period. MMAS- 8 score，satisfaction score of drug communication dimension and score of overall satisfactionin of intervention group were obviously higher than control group （P＜0.01）. There was no significant difference in blood pressure standard rate ，blood lipid standard rate ，the incidence of adverse drug reaction ，and the incidence of acute coronary events between 2 groups（P＞0.05）. The total cost of intervention group was lower than that of control group （P＜ 0.01）；the results of sensitivity analysis were consistent with those of cost minimization analysis. CONCLUSIONS Pharmacists implement MTM service for patients with stable coronary disease can reduce total cost ，save medical resources and has economic advantages.
